On To The Next One

MPM Capital's investment in pulmonary and cardiovascular play Aires Pharmaceuticals Inc. will be the last deal out of its first MPM Bio IV NVS Strategic Fund.

MPM Capital's Todd Foley told Ebb & Flow he now will start to invest a second fund, but declined to disclose its size...